Stable chronic hemodialysis porcine model via renal vein catheterization of the posterior vena cava

For millions of people around the world, failing kidneys mean a life tethered to a machine. When the body can no longer filter its own blood, a treatment called hemodialysis takes over, pumping blood out of the body, cleaning it through a filter, and returning it. While this life-saving procedure is well-established, the tools used to connect patients to these machines are not perfect. Doctors often struggle with catheters that get clogged, form clots, or damage delicate heart valves over time. To make these devices better, scientists need to test them on living animals that mimic the human condition of kidney failure. However, creating a stable, long-term model for this kind of testing has been a persistent hurdle. Small animals like mice are too tiny to hold the necessary equipment, while larger animals often cannot survive the repeated stress of dialysis or the surgery required to remove their kidneys.

A team of researchers at Jichi Medical University in Japan has now developed a new way to solve this problem using miniature pigs. These animals are the ideal size for testing medical devices meant for humans, and their bodies function in ways that are surprisingly similar to our own. The researchers set out to create a pig that could survive for weeks while undergoing regular dialysis, just like a human patient. Their goal was not just to keep the animals alive, but to find the most reliable way to insert the tubes that carry blood to and from the machine. By comparing different surgical approaches and focusing on the weight of the animals, they discovered a specific method that kept the blood flowing smoothly and avoided the dangerous complications that had plagued previous attempts.

The study began with two groups of miniature pigs: the Göttingen variety and the Nippon Institute for Biological Science variety. Before any testing could begin, the researchers had to induce kidney failure in the animals. This was done by surgically removing both kidneys, a procedure that left the pigs unable to filter their own blood. Once the kidneys were gone, the team faced a critical decision: where to place the catheter, the tube that would serve as the lifeline for dialysis. In one group, they followed the standard human practice of inserting the tube into the jugular vein in the neck. In the other group, they tried a different route, threading the catheter through the right renal vein—the vessel that normally drains the kidney—so that the tip would rest in the large vein running down the back of the body, known as the posterior vena cava.

The results of this comparison were clear and decisive. The pigs with catheters placed in the neck struggled significantly. Many of them developed a thick, sticky coating of fibrin, a protein involved in clotting, which wrapped around the tube like a sheath. This coating made it difficult to draw blood, and in some cases, the tube became completely blocked by a clot. Worse still, the movement of the catheter tip inside the heart caused physical damage, injuring the tricuspid valve and leading to fatal complications in at least one animal. In contrast, the pigs with catheters inserted through the renal vein into the large central vein remained stable. The blood flowed freely, and the tubes stayed open for much longer without the formation of those obstructive clots.

Body weight played a crucial role in the success of the experiment as well. The researchers found that heavier pigs, those weighing between 30 and 40 kilograms, survived significantly longer than their lighter counterparts. The lighter pigs, many of whom weighed under 30 kilograms, lost weight rapidly after surgery and often succumbed to the stress of the procedure. The heavier animals were able to maintain their strength and tolerate the dialysis sessions, which were performed three times a week for up to 39 days. During this time, the medical team monitored the pigs' blood closely. As long as the catheters remained open, the levels of waste products like urea and creatinine were kept under control, proving that the dialysis was working effectively. The pigs' blood counts did drop, a common side effect of kidney failure, but the core function of the treatment remained intact.

The success of the renal vein approach offers a practical solution for future research. The researchers discovered that a 12-fr catheter, a specific size of tube, worked best when placed in the renal vein of pigs in the 30 to 40-kilogram range. This setup allowed for stable dialysis without the need for extra blood thinners between sessions and avoided the frequent reinsertions that were required for the neck catheters. The study suggests that the anatomy of the pig's neck is simply too narrow and the distance to the heart too short for the standard human catheters to work well, leading to the high rate of complications. By moving the entry point to the renal vein, the catheter tip sits in a more spacious and stable location, reducing the risk of injury and blockage.

This new model provides a reliable platform for scientists to test new dialysis machines, filters, and catheters before they are ever used on human patients. It also opens the door to studying the long-term effects of kidney failure, such as bone disorders and heart changes, in a living system that closely resembles our own. While the study was limited to a period of about a month, the findings are strong enough to suggest that this method is a viable path forward. The researchers acknowledge that keeping the animals healthy for even longer will require better nutritional support and management of anemia, but the foundation has been laid. By identifying the right animal size and the correct surgical route, this work brings us a step closer to improving the safety and effectiveness of life-saving dialysis treatments for people everywhere.